In this study, we performed bioinformatic analyses of bladder cancer database and unveiled significant high expression of SPHK1 but not SPHK2 with clinical BS subtype [44, 45], a typically invasive cancer, or LI subtype [44, 45] that is associated with chemo resistant. Here, SPHK2 is linked to urinary bladder carcinoma.